Search results
AI finds plethora of potential sources for new antibiotics to fight superbugs | FOX 28 Spokane
FOX 28 Spokane· 2 days agoHundreds of thousands of potential sources of new antibiotics to fight deadly drug-resistant...
Canadian Optimi To Export Magic Mushrooms To Australia - Lululemon Athletica (NASDAQ:LULU), Optimi...
Benzinga· 1 day agoThe Magic Mushrooms and MDMA market is hitting new milestones. Canada has licensed Optimi Health...
Magic Mushrooms Get Canadian Export License in Psychedelic Race
Bloomberg via Yahoo Finance· 4 days ago(Bloomberg) -- Canada has licensed a startup to export psychedelics to Australia for patient use,...
Live from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in...
Benzinga· 5 days agoSUZHOU, China, and ROCKVILLE, Md., June 1, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related
Bone Medications Transform Into Fungal Fighters in Groundbreaking Study
SciTechDaily· 2 days agoCombining azoles with bisphosphonates enhances the treatment of fungal infections, showing...
U.S. maternal death rate far exceeds that of other wealthy nations
UPI· 3 days agoIn 2022, U.S. women had a death rate from complications of pregnancy and childbirth of 22 deaths per...
FDA Clearance For Gastrointestinal Parasite Detection Kit
StreetInsider· 3 days agoMELBOURNE, Australia, June 4, 2024 /PRNewswire/ -- Genetic Signatures Limited [ASX:GSS] ("GSS" or the "Company"), a global molecular diagnostics...
VGXI Inc. announces a strategic partnership with Sutro Biopharma Inc. to support growing clinical...
Forrest City Times-Herald· 4 days agoSutro, a clinical-stage oncology company pioneering site...the randomized portion (Part 2) of REFRαME-O1, a global, registration-directed clinical trial of luvelta (NCT05870748) in platinum- ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 5 days agoInnovent Presents Phase 1 Clinical Data of First-in-class PD-1/IL-2α Bispecific Antibody Fusion Protein (IBI363) in Melanoma, Colorectal Cancer and other Solid Tumors at the 2024 ASCO Annual Meeting PR Newswire SAN FRANCISCO, U.S. and SUZHOU, China